http://old.affibody.se.hemsida.eu/press-news/ 2023-01-05T12:00:02+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2009/ 2016-09-05T09:53:32+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2010/ 2016-09-05T09:54:43+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2010/ 2016-09-05T09:56:55+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-amylin-pharmaceuticals-inc-enter-into-a-license-agreement-regarding-the-albumod-platform/ 2016-09-05T09:57:19+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2010/ 2016-09-05T09:57:41+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2010/ 2016-09-05T11:30:55+00:00 http://old.affibody.se.hemsida.eu/algeta-asa-obtains-licenses-to-develop-cancer-therapeutics-based-on-affibody-technology-for-two-oncology-targets/ 2016-09-05T11:31:15+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2011/ 2016-09-05T11:31:36+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2011/ 2016-09-05T11:32:36+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-ge-healthcare-expands-its-relationship-in-the-field-of-large-scale-affinity-purification/ 2016-09-05T11:33:08+00:00 http://old.affibody.se.hemsida.eu/affibody-appoints-dr-fredrik-frejd-as-vp-research/ 2016-09-05T11:33:31+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2011/ 2016-09-05T11:34:29+00:00 http://old.affibody.se.hemsida.eu/first-in-human-whole-body-her2-receptor-mapping-using-affibody-molecular-imaging-with-aby-025/ 2016-09-05T11:34:51+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-nuclisome-ab-to-develop-cancer-therapeutics/ 2016-09-05T11:36:10+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2011/ 2016-09-05T11:39:08+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-creative-antibiotics-ab-enter-collaboration-to-develop-targeted-antibiotics/ 2016-09-05T11:39:15+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2012/ 2016-09-05T11:39:38+00:00 http://old.affibody.se.hemsida.eu/ge-healthcare-and-affibody-ab-to-collaborate-on-her2-specific-pet-imaging-agent-for-breast-and-gastric-cancer/ 2016-09-05T11:41:35+00:00 http://old.affibody.se.hemsida.eu/sobi-enters-research-collaboration-with-affibody-within-the-il-1-field/ 2016-09-05T11:41:58+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2012/ 2016-09-05T11:42:23+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-sept-2012/ 2016-09-05T11:42:43+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2012/ 2016-09-05T11:43:02+00:00 http://old.affibody.se.hemsida.eu/first-patient-included-in-pet-imaging-study-of-her2-expression-in-metastatic-breast-cancer/ 2016-09-05T11:47:32+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-receives-swedenbio-award-2013/ 2016-09-05T11:48:00+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-daewoong-pharmaceutical-co-ltd-enter-into-a-license-agreement-regarding-the-albumod-platform/ 2016-09-05T11:48:57+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-arsstamma/ 2016-09-05T11:49:19+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-abclon-enter-into-a-license-agreement-regarding-the-affibody-technology/ 2016-09-05T11:49:46+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2013/ 2016-09-05T11:51:34+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-daiichi-sankyo-enter-into-a-license-agreement-regarding-the-albumod-platform/ 2016-09-05T11:52:12+00:00 http://old.affibody.se.hemsida.eu/resolutions-from-affibodys-annual-general-meeting-agm/ 2016-09-05T11:52:33+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-extra-bolagsstamma/ 2016-09-05T11:52:52+00:00 http://old.affibody.se.hemsida.eu/resolutions-from-affibodys-extraordinary-general-meeting-egm/ 2016-09-05T11:53:18+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2013/ 2016-09-05T11:54:37+00:00 http://old.affibody.se.hemsida.eu/new-molecular-imaging-agents-being-developed-for-fluorescence-guided-brain-cancer-surgery/ 2016-09-05T11:54:52+00:00 http://old.affibody.se.hemsida.eu/eu-funded-effort-to-develop-new-stroke-therapies/ 2016-09-05T11:55:10+00:00 http://old.affibody.se.hemsida.eu/sobi-announces-phase-i-complement-inhibitor-program/ 2016-09-05T11:55:35+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2013/ 2016-09-05T11:55:55+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2013/ 2016-09-05T11:57:44+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-arsstamma-2/ 2016-09-05T11:58:11+00:00 http://old.affibody.se.hemsida.eu/first-patient-included-in-pet-imaging-study-of-her2-expression-in-breast-cancer/ 2016-09-05T11:58:35+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2014/ 2016-09-05T11:59:00+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2014/ 2016-09-05T11:59:18+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2014/ 2016-09-05T12:01:07+00:00 http://old.affibody.se.hemsida.eu/nordic-nanovector-and-affibody-collaborate-on-advanced-radio-immunotherapies-program-for-multiple-myeloma/ 2016-09-05T12:01:25+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2014/ 2016-09-05T12:01:47+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2015/ 2016-09-05T12:02:10+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-arsstamma-3/ 2016-09-05T12:02:33+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-and-biotest-ag-enter-into-a-research-license-and-option-agreement-regarding-the-albumod-platform/ 2016-09-05T12:03:52+00:00 http://old.affibody.se.hemsida.eu/imaging-study-highlighted-at-asco-reveals-many-women-may-receive-wrong-her2-therapy/ 2016-09-05T12:04:08+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2015/ 2016-09-05T12:04:29+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2015/ 2016-09-05T12:04:49+00:00 http://old.affibody.se.hemsida.eu/affibody-receives-clinical-milestone-from-daiichi-sankyo/ 2016-09-05T12:05:05+00:00 http://old.affibody.se.hemsida.eu/affibody-licenses-albumod-half-life-extension-technology-to-medimmune/ 2016-09-05T12:06:34+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2015/ 2016-09-05T12:07:04+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-extra-bolagsstamma-2/ 2016-09-05T12:07:24+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-enter-into-an-option-agreement-regarding-il-17-targeting-molecules-in-ophthalmology/ 2016-09-05T12:07:41+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-enter-into-an-option-agreement-regarding-cancer-targeting-molecules/ 2016-09-05T12:08:01+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-arsstamma-4/ 2016-09-05T12:09:20+00:00 http://old.affibody.se.hemsida.eu/sobi-signs-licensing-agreement-with-affibody-for-il-1/ 2016-09-05T12:09:38+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-initial-results-from-a-phase-i-study-of-aby-035/ 2016-09-05T12:09:55+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2016/ 2016-09-05T12:10:16+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2016/ 2016-09-05T12:10:31+00:00 http://old.affibody.se.hemsida.eu/affibody-unexpected-discovery-made-by-swedish-researchers-within-the-field-of-alzheimer-newly-discovered-protein-inhibits-the-formation-of-the-precursor-to-alzheimers-plaques/ 2016-09-05T12:32:37+00:00 http://old.affibody.se.hemsida.eu/affibody-appoints-david-bejker-as-ceo/ 2016-09-05T12:32:59+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2008/ 2016-09-05T12:33:19+00:00 http://old.affibody.se.hemsida.eu/biovitrum-gets-access-to-affibody-technology/ 2016-09-05T12:33:40+00:00 http://old.affibody.se.hemsida.eu/affibody-interim-report-january-to-march-2009/ 2016-09-05T12:34:52+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2009/ 2016-09-05T12:35:16+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september/ 2016-09-05T12:35:55+00:00 http://old.affibody.se.hemsida.eu/affibodys-collaborator-dartmouth-wins-fda-approval-for-aid-to-guide-cancer-surgery/ 2016-10-13T07:44:43+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2016/ 2016-11-18T07:00:10+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2016/ 2017-02-24T09:10:21+00:00 http://old.affibody.se.hemsida.eu/affibody-to-initiate-phase-ii-psoriasis-trials-for-lead-candidate-aby-035/ 2017-05-10T06:07:01+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2017/ 2017-05-19T06:00:09+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-arsstamma-5/ 2017-05-24T07:55:26+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2017/ 2017-08-23T06:00:03+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-presentation-of-interim-data-from-phase-iii-clinical-trial-of-aby-035-at-european-academy-of-dermatology-and-venereology/ 2017-09-06T06:00:07+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-extra-bolagsstamma-3/ 2017-11-08T10:07:52+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2017/ 2017-11-17T12:00:01+00:00 http://old.affibody.se.hemsida.eu/basta-aktieagare-i-affibody-medical-ab/ 2017-12-01T07:15:02+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2017/ 2018-02-23T07:01:02+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-participation-in-the-cellnova-center/ 2018-02-26T07:30:01+00:00 http://old.affibody.se.hemsida.eu/affibody-raises-sek-200m-in-rights-issue/ 2018-03-08T07:00:11+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-first-dosing-in-a-phase-i-trial-of-aby-039-for-autoimmune-diseases/ 2018-03-13T07:00:02+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-first-psoriasis-patients-dosed-in-a-phase-ii-clinical-trial-of-aby-035/ 2018-03-21T07:00:10+00:00 http://old.affibody.se.hemsida.eu/kallelse-till-arsstamma-6/ 2018-05-09T07:00:07+00:00 http://old.affibody.se.hemsida.eu/affibody-presents-at-bioequity-europe/ 2018-05-11T07:00:05+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2018/ 2018-05-18T07:00:08+00:00 http://old.affibody.se.hemsida.eu/affibody-presents-at-anglonordic-life-science/ 2018-05-21T07:00:07+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2018/ 2018-08-23T06:15:01+00:00 http://old.affibody.se.hemsida.eu/new-her2-pet-study-uses-affibodys-aby-025-tracer-to-individualize-breast-cancer-treatment/ 2018-09-24T11:00:08+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2018/ 2018-11-16T07:30:33+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-option-exercise-by-biotest/ 2018-12-04T07:58:25+00:00 http://old.affibody.se.hemsida.eu/affibody-completes-enrollment-in-phase-2-psoriasis-trial-of-aby-035/ 2019-02-20T08:00:04+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2018/ 2019-02-21T16:12:07+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-fully-guaranteed-rights-issue/ 2019-02-22T08:00:04+00:00 http://old.affibody.se.hemsida.eu/alexion-and-affibody-announce-partnership-to-co-develop-anti-fcrn-affibody-molecule/ 2019-03-20T10:31:02+00:00 http://old.affibody.se.hemsida.eu/interview-with-affibodys-ceo-in-swedish/ 2019-03-28T08:27:00+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2019/ 2019-05-17T06:00:05+00:00 http://old.affibody.se.hemsida.eu/affibody-enters-into-agreement-with-3p-biopharmaceuticals-for-production-of-aby-035/ 2019-05-27T09:07:23+00:00 http://old.affibody.se.hemsida.eu/notice-of-agm-kallelse-till-arsstamma/ 2019-05-27T13:35:54+00:00 http://old.affibody.se.hemsida.eu/affibody-to-present-at-affinity-2019/ 2019-06-17T06:45:11+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-interim-analysis-in-phase-2-psoriasis-trial-of-aby-035/ 2019-07-16T14:00:10+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2019/ 2019-08-23T06:30:15+00:00 http://old.affibody.se.hemsida.eu/affibody-and-ge-healthcare-to-collaborate-on-development-of-affibody-pet-imaging-tracers/ 2019-09-20T06:15:04+00:00 http://old.affibody.se.hemsida.eu/affibody-relocates-to-the-karolinska-institute-campus-in-solna/ 2019-09-23T06:05:07+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2019/ 2019-11-15T07:30:11+00:00 http://old.affibody.se.hemsida.eu/notice-of-egm-kallelse-till-extra-bolagsstamma/ 2020-02-03T12:20:01+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2019/ 2020-02-21T12:01:51+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-option-exercise-by-daewoong/ 2020-04-30T07:08:02+00:00 http://old.affibody.se.hemsida.eu/affibody-and-inmagene-announce-strategic-partnership-to-develop-aby-035-a-phase-2-drug-candidate-with-best-in-class-potential-for-auto-immune-diseases/ 2020-05-15T06:00:09+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2020/ 2020-05-15T07:30:07+00:00 http://old.affibody.se.hemsida.eu/notice-to-attend-annual-general-meeting/ 2020-05-25T15:00:03+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-termination-of-aby-039-fcrn-program/ 2020-06-15T05:30:23+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-positive-top-line-data-from-phase-2-proof-of-concept-trial-of-aby-035-in-psoriasis/ 2020-06-15T06:00:03+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2020/ 2020-08-21T12:30:02+00:00 http://old.affibody.se.hemsida.eu/affibody-announces-initiation-of-confirmatory-phase-2-trial-of-aby-035-in-psoriatic-arthritis-patients/ 2020-11-10T13:30:12+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-september-2020/ 2020-11-13T07:55:11+00:00 http://old.affibody.se.hemsida.eu/affibody-and-inmagene-announce-ind-clearance-for-izokibep-aby-035-for-the-treatment-of-ankylosing-spondylitis/ 2021-02-10T07:30:06+00:00 http://old.affibody.se.hemsida.eu/year-end-report-2020/ 2021-02-19T07:15:27+00:00 http://old.affibody.se.hemsida.eu/affibody-and-inmagene-announce-ind-clearance-for-izokibep-aby-035-for-the-treatment-of-non-infectious-non-anterior-uveitis/ 2021-03-09T08:01:06+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-march-2021/ 2021-05-14T07:00:06+00:00 http://old.affibody.se.hemsida.eu/notice-to-attend-annual-general-meeting-2/ 2021-06-02T06:30:18+00:00 http://old.affibody.se.hemsida.eu/affibody-appoints-dr-nikolai-brun-as-cmo/ 2021-08-20T07:30:35+00:00 http://old.affibody.se.hemsida.eu/affibody-and-inmagene-announce-first-patient-dosed-in-the-global-phase-2-aspire-trial-of-izokibep-for-patients-with-active-ankylosing-spondylitis/ 2021-08-25T11:01:43+00:00 http://old.affibody.se.hemsida.eu/interim-report-january-to-june-2021/ 2021-08-27T09:30:04+00:00 http://old.affibody.se.hemsida.eu/phase-2-linnaea-study-presented-at-euretina/ 2021-09-10T13:20:37+00:00 http://old.affibody.se.hemsida.eu/affibody-enters-agreement-with-acelyrin-for-the-development-and-commercialization-of-izokibep-at-a-total-deal-value-of-usd-305-million-plus-royalties/ 2021-11-16T12:00:24+00:00 http://old.affibody.se.hemsida.eu/affibody-enters-agreement-with-acelyrin-for-the-development-and-commercialization-of-izokibep-at-a-total-deal-value-of-usd-305-million-plus-royalties-2/ 2021-11-16T12:00:07+00:00 http://old.affibody.se.hemsida.eu/notice-to-attend-extraordinary-general-meeting/ 2021-12-02T18:30:06+00:00 http://old.affibody.se.hemsida.eu/notice-to-attend-extraordinary-general-meeting-2/ 2021-12-02T18:30:04+00:00 http://old.affibody.se.hemsida.eu/phase-2-her2-targeting-study-presented-at-sabcs/ 2021-12-09T16:50:02+00:00 http://old.affibody.se.hemsida.eu/affibody-ab-acelyrin-inc-and-inmagene-announce-positive-interim-results-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis/ 2021-12-14T10:00:04+00:00 http://old.affibody.se.hemsida.eu/lokon-pharma-and-affibody-initiates-a-collaboration-to-develop-novel-cancer-therapeutics/ 2022-01-12T08:00:07+00:00 http://old.affibody.se.hemsida.eu/rallybio-announces-phase-1-initiation-with-rlyb116/ 2022-03-07T14:10:06+00:00 http://old.affibody.se.hemsida.eu/notice-of-annual-general-meeting-in-affibody-medical-ab-publ/ 2022-04-20T12:15:03+00:00 http://old.affibody.se.hemsida.eu/affibody-acelyrin-and-inmagene-bio-announce-positive-results-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis/ 2022-05-03T12:05:19+00:00 http://old.affibody.se.hemsida.eu/report-from-annual-general-meeting-in-affibody-medical-ab-publ/ 2022-05-19T12:50:04+00:00 http://old.affibody.se.hemsida.eu/affibody-acelyrin-and-inmagene-biopharmaceuticals-announce-data-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis-presented-during-2022-european-alliance-of-associations-for/ 2022-06-03T09:15:32+00:00 http://old.affibody.se.hemsida.eu/affibody-acelyrin-and-inmagene-biopharmaceuticals-announce-data-from-global-phase-2-trial-of-izokibep-in-patients-with-psoriatic-arthritis-presented-during-2022-european-alliance-of-associations-for-2/ 2022-06-03T09:15:03+00:00 http://old.affibody.se.hemsida.eu/affibodys-partner-rallybio-announces-positive-phase-1-results-for-rlyb116/ 2022-11-07T14:15:12+00:00 http://old.affibody.se.hemsida.eu/affibody-announce-positive-additional-izokibep-phase-2-data-in-patients-with-psoriatic-arthritis-psa-will-be-presented-at-american-college-of-rheumatology-acr-convergence-2022/ 2022-11-08T15:00:04+00:00 http://old.affibody.se.hemsida.eu/affibody-signs-e20-million-loan-agreement-with-the-eib-to-finance-the-development-of-next-generations-biopharmaceuticals-against-cancer-and-inflammatory-diseases/ 2022-12-23T07:00:09+00:00 http://old.affibody.se.hemsida.eu/first-her2-low-patients-enrolled-in-phase-2-basket-trial-using-affibodys-pet-imaging-agent-aby-025/ 2023-01-04T07:00:16+00:00 http://old.affibody.se.hemsida.eu/positive-top-line-clinical-data-for-izokibep-in-hidradenitis-suppurativa/ 2023-01-05T12:00:02+00:00